Clinical Trials Logo

Clinical Trial Summary

Intramuscular injection (IMI) is the process of administering a drug treatment into muscle tissue. The transmission of skills in this care practice is essentially based on the experience of peers. In France, there are no official guidelines for this technical procedure. Haloperidol decanoate is widely used in psychiatry. This long-acting antipsychotic treatment considerably reduces the risk of relapse and hospitalization. It is administered by IMI. This treatment is invasive, painful and risks complications for the patient. Nurses must ensure that the treatment is as painless as possible, and adapt their practice in line with current recommendations. Among the various IMI techniques available, the "Z-track" and the "Airlock" limit leakage into subcutaneous tissues when the needle is withdrawn, by locking the active product into the muscular tissues. According to an exploratory study (n=303), 73% of nurses observe active product leakage after injections, and 89% of nurses are not familiar with either the "Z-track" or "Airlock" techniques. Many foreign studies have been carried out to demonstrate the relevance of these techniques, particularly in terms of pain reduction during treatment, but the results have yet to be confirmed. The investigators hypothesize that the combined use of the "Z-track" and "Airlock" techniques during intramuscular injection of Haloperidol decanoate is more effective in reducing patient pain than usual practice.


Clinical Trial Description

This is a multicenter, prospective, randomized, double-blind, controlled, study in 2 parallel groups. Experimental and control administration protocols will be standardized to harmonize injection practices between the different nurses providing care, and to control some variables. Nurses will have been trained in these protocols and in experimental injection techniques. The experimental group will be offered an intramuscular injection using the "Z-track" and "Airlock" techniques, while the control group will have an "usual" injection. An intermediate analysis of futility and efficacy is planned once 50% of the planned sample has completed the study. The object of the research is the intramuscular injection procedure - Product injected: haloperidol decanoate (Haldol Decanoas®). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05995457
Study type Interventional
Source Centre Hospitalier St Anne
Contact Rayan BCHINI, IPA
Phone 33 1 42 11 75 90
Email rayan.francoisbchini@gh-paulguiraud.fr
Status Not yet recruiting
Phase N/A
Start date September 1, 2023
Completion date November 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT04559529 - Pharmacological Modulation of Hippocampal Activity in Psychosis 2 Phase 2
Recruiting NCT06134661 - Accelerated rTMS for Psychomotor Slowing N/A
Completed NCT05759091 - Effect of Applying Cognitive Defusion Techniques on Mindful Awareness, Cognitive Fusion and Believability of Delusions Among Clients With Schizophrenia N/A
Completed NCT04777266 - Music Therapy for People With Schizophrenia and Relates Psychosis. N/A
Not yet recruiting NCT06341517 - Brain Circuitry Therapeutics for Schizophrenia N/A
Not yet recruiting NCT05550155 - Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations N/A
Terminated NCT04277936 - Pharmacologic Modulation of Hippocampal Activity in Psychosis Phase 2
Active, not recruiting NCT04748679 - Cognitive Behavioral Therapy (CBT) Study Evaluating the Updating of Persecutory Beliefs N/A
Recruiting NCT05858255 - Hjernegym - Effects of Exergaming in Psychosis: a Clinical Intervention Study N/A
Not yet recruiting NCT05763966 - Uppsala Psychosis Cohort
Not yet recruiting NCT05731414 - Outcomes From Remediation and Behavioural Intervention Techniques N/A
Completed NCT04898270 - Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients Phase 4
Completed NCT04659161 - A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2) Phase 3
Completed NCT04260763 - Evaluating a Novel Mobile App for Social Cognition in Psychosis N/A
Recruiting NCT04853485 - Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes N/A
Completed NCT04738123 - A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3) Phase 3
Recruiting NCT05445180 - Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use N/A
Not yet recruiting NCT06375902 - The Fragility of Metaphors (FraMe): Learning, Loosing, and How to Train Them
Completed NCT04773171 - Efficacy of Computer-assisted Cognitive Remediation in Patients With Schizophrenia N/A